DeMaagd, G., & Philip, A. (2015). Parkinson’s disease and its management: Part 1: Disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. Pharmacy and Therapeutics, 40(8), 504–532.

PubMed  PubMed Central  Google Scholar 

Liaison, C. A. P., (2015) Parkinson’s disease: Challenges, progress, and promise, NINDS. September 30, 2015

Antonina Kouli, K. M. T., & Wei-Li K., (2018) Parkinson’s disease: Pathogenesis and clinical aspects. NIH NLM

Grover, S., et al. (2015). Psychiatric aspects of Parkinson’s disease. Journal of Neurosciences in Rural Practice, 6(1), 65–76.

Article  PubMed  PubMed Central  Google Scholar 

Lubomski, M., Davis, R. L., & Sue, C. M. (2021). Health-related quality of life for Parkinson’s disease patients and their caregivers. Journal of Movement Disorders, 14(1), 42–52.

Article  PubMed  PubMed Central  Google Scholar 

Lee, J., et al. (2019). Quality of life of caregivers of individuals with Parkinson’s disease. Rehabilitation Nursing, 44(6), 338–348.

Article  PubMed  Google Scholar 

Bhimani, R. (2014). Understanding the burden on caregivers of people with Parkinson’s: A scoping review of the literature. Rehabilitation Research and Practice, 2014, 718527.

Article  PubMed  PubMed Central  Google Scholar 

Thieken, F., & van Munster, M. (2021). Deriving implications for care delivery in Parkinson’s disease by co-diagnosing caregivers as invisible patients. Brain Sciences, 11(12), 1629.

Article  CAS  PubMed  PubMed Central  Google Scholar 

WHO (2023). Parkinson disease

S. Heath, R., MS, & E. Lanier, RN, MS. (2023). Parkinson’s disease and caregiving

Hoffmann & Rodrigues, S. E. A. (2016). The challenging roles of informal carers

Norlin, J. M., Kellerborg, K., Persson, U., Åström, D. O., Hagell, P., Martinez-Martin, P., & Odin, P. (2023). Clinical impression of severity index for Parkinson’s disease and its association to health-related quality of life. Movement Disorders Clinical Practice, 10(3), 392–398.

Article  PubMed  PubMed Central  Google Scholar 

Afentou, N., et al. (2019). Economic evaluation of interventions in Parkinson’s disease: A systematic literature review. Movement Disorders Clinical Practice, 6(4), 282–290.

Article  PubMed  PubMed Central  Google Scholar 

Jørgensen, J., Servos, S., & Kefalas, P. (2018). The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson’s disease. J Mark Access Health Policy, 6(1), 1500419.

Article  PubMed  PubMed Central  Google Scholar 

Liu, X., et al. (2023). An occupational health survey on health utility and occupational diseases in Chinese university staff to inform cost-utility analysis. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2022.1022344

Article  PubMed  PubMed Central  Google Scholar 

Mar, J., et al. (2023). Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents. BMC Psychiatry, 23(1), 178.

Article  PubMed  PubMed Central  Google Scholar 

Wu, H., et al. (2021). Cost-utility analysis of palliative care in patients with advanced cancer: A retrospective study. BMC Palliative Care, 20(1), 126.

Article  PubMed  PubMed Central  Google Scholar 

Liberati, A., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Journal of Clinical Epidemiology, 62(10), e1-34.

Article  PubMed  Google Scholar 

Balestroni, G., & Bertolotti, G. (2012). EuroQol-5D (EQ-5D): An instrument for measuring quality of life. Monaldi Archives for Chest Disease, 78(3), 155–159.

PubMed  Google Scholar 

Pattanaphesaj, J., & Thavorncharoensap, M. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health and Quality of Life Outcomes, 13, 14.

Article  PubMed  PubMed Central  Google Scholar 

Claire, M. N., et al. (2016). The EQ-5D-5L health status questionnaire in COPD: Validity, responsiveness and minimum important difference. Thorax, 71(6), 493.

Article  Google Scholar 

Janssen, M. F., Bonsel, G. J., & Luo, N. (2018). Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. PharmacoEconomics, 36(6), 675–697.

Article  PubMed  PubMed Central  Google Scholar 

Moradi, N., et al. (2022). Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran. Frontiers in Oncology, 12, 1052155.

Article  PubMed  PubMed Central  Google Scholar 

McCaffrey, N., et al. (2016). Health-related quality of life measured using the EQ-5D–5L: South Australian population norms. Health and Quality of Life Outcomes, 14(1), 133.

Article  PubMed  PubMed Central  Google Scholar 

Antonini, A., et al. (2015). Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson’s disease patients; 12-month interim outcomes. Parkinsonism & Related Disorders, 21, 231–235.

Article  Google Scholar 

A’Campo, L. E. I., et al. (2010). The benefits of a standardized patient education program for patients with Parkinson’s disease and their caregivers. Parkinsonism and Related Disorders, 16(2), 89–95.

Article  PubMed  Google Scholar 

Carter, B., et al. (2021). A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease. PloS ONE, 16(6), e0251484.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balzer-Geldsetzer, M., et al. (2018). Quality of life in a German cohort of Parkinson’s patients assessed with three different measures. Journal of Neurology, 265(11), 2713–2722.

Article  CAS  PubMed  Google Scholar 

Bettecken, K., et al. (2017). No relevant association of kinematic gait parameters with Health-related Quality of Life in Parkinson’s disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0176816

Article  PubMed  PubMed Central  Google Scholar 

Bock, M. A., et al. (2022). Association of Motor and nonmotor symptoms with health-related quality of life in a large online cohort of people with Parkinson disease. Neurology, 98(22), E2194–E2203.

Article  PubMed  PubMed Central  Google Scholar 

Brettschneider, C., et al. (2013). Relative impact of multimorbid chronic conditions on health-related quality of life–results from the MultiCare Cohort Study. PloS ONE, 8(6), e66742.

Article  PubMed  PubMed Central  Google Scholar 

Cano-de-la-Cuerda, R., et al. (2011). Axial rigidity and quality of life in patients with Parkinson’s disease: A preliminary study. Quality of Life Research, 20(6), 817–823.

Article  PubMed  Google Scholar 

Morley, D., et al. (2016). Validation of the Oxford participation and activities questionnaire. Patient Related Outcome Measures, 7, 73–80.

Article  PubMed  PubMed Central  Google Scholar 

Kelly, D. H., et al. (2012). Health-related quality of life and strain in caregivers of Australians with Parkinson’s disease: An observational study. BMC Neurology, 12, 57.

Article  PubMed  PubMed Central  Google Scholar 

Cubo, E., et al. (2014). Comparison of the clinical profile of Parkinson’s disease between Spanish and Cameroonian cohorts. Journal of the Neurological Sciences, 336, 122–126.

Article  PubMed  Google Scholar 

Torny, F., et al. (2018). Factors associated with spousal burden in Parkinson’s disease. Revue Neurologique, 174(10), 711–715.

Article  CAS  PubMed  Google Scholar 

Genc, G., et al. (2016). Socioeconomic status may impact functional outcome of deep brain stimulation surgery in Parkinson’s disease. Neuromodulation: Journal of the International Neuromodulation Society, 19(1), 25–30.

Article  PubMed  Google Scholar 

Tamás, G., et al. (2014). Quality of life and costs in Parkinson’s disease: a cross sectional study in Hungary. PloS ONE, 9(9), e107704.

Article  PubMed  PubMed Central  Google Scholar 

Goel, A., Narayan, S. K., & Sugumaran, R. (2022). A telephonic survey of health-related quality of life of outpatient department dropout Parkinson’s disease patients during the COVID-19 pandemic. Acta Neurologica Belgica, 122(2), 519–523.

Article  PubMed  PubMed Central  Google Scholar 

Grigoriou, S., et al. (2021). Effects of safinamide on pain in patients with fluctuating Parkinson’s disease. Brain and Behavior. https://doi.org/10.1002/brb3.2336

Article  PubMed  PubMed Central  Google Scholar 

Shin, H., et al. (2012). Caregiver burden in Parkinson disease with dementia compared to Alzheimer disease in Korea. Journal of Geriatric Psychiatry and Neurology, 25(4), 222–226.

Article  PubMed  Google Scholar 

Horváth, K., et al. (2014). Test-retest validity of Parkinson’s disease sleep scale 2nd version (PDSS-2). Journal of Parkinson’s Disease, 4(4), 687–691.

Article  PubMed  Google Sch